Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27987850 | 0.88 | MEN1 (0.42) | RAB9AMEN1KMT2AHRH3 | |
| SCHEMBL2286309 | 0.83 | PTGES (0.36) | SMN1; SMN2CTSKPTGESALOX5PPARG | |
| SCHEMBL6319500 | 0.80 | CHRM2 (0.44) | MEN1KMT2A | |
| SCHEMBL7404908 | 0.79 | CA1 (0.38) | RAB9ASMN1; SMN2CTSKPTGESALOX5 | |
| SCHEMBL20170449 | 0.78 | RAB9A (0.55) | RAB9ASMN1; SMN2MEN1KMT2AHRH3 | |
| SCHEMBL755823 | 0.78 | RAB9A (0.50) | RAB9ASMN1; SMN2ALDH1A1HPGDMEN1 | |
| SCHEMBL6755988 | 0.77 | SIGMAR1 (0.46) | — | |
| SCHEMBL5962154 | 0.76 | PPARG (0.44) | SMN1; SMN2ALDH1A1HPGDPPARGTSHR | |
| SCHEMBL90733 | 0.74 | RAB9A (0.58) | RAB9ASMN1; SMN2MEN1KMT2AHRH3 | |
| SCHEMBL75088 | 0.74 | RAB9A (0.53) | RAB9ASMN1; SMN2ALDH1A1HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2012500209-A | — | — | 2012-01-05 | — | — | JP | claimed |
| EP-2312939-A1 | ANTIMICROBIAL GEL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-04-27 | — | — | EP | claimed |
| WO-2010019723-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2010-02-18 | — | — | WO | claimed |
| EP-1021511-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | Bush Boake Allen Inc. (US) | 2000-07-26 | — | — | EP | claimed |
| EP-0966517-A1 | BLEACHING AND CLEANING COMPOSITIONS CONTAINING FRAGRANCES | LONZA INC. (US) | 1999-12-29 | — | — | EP | claimed |
| WO-1998036049-A1 | BLEACHING AND CLEANING COMPOSITIONS CONTAINING FRAGRANCES | LONZA INC. (US) | 1998-08-20 | — | — | WO | claimed |
| WO-1998006804-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | BUSH BOAKE ALLEN INC. (US) | 1998-02-19 | — | — | WO | claimed |
| EP-2531026-A1 | POLYSACCHARIDE BASED ANTIMICROBIAL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2012-12-12 | — | — | EP | disclosed |
| WO-2011097324-A1 | POLYSACCHARIDE BASED ANTIMICROBIAL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| EP-2312939-A1 | ANTIMICROBIAL GEL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010019723-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2010-02-18 | — | — | WO | disclosed |
| EP-1021511-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | Bush Boake Allen Inc. (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-0966517-A1 | BLEACHING AND CLEANING COMPOSITIONS CONTAINING FRAGRANCES | LONZA INC. (US) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998036049-A1 | BLEACHING AND CLEANING COMPOSITIONS CONTAINING FRAGRANCES | LONZA INC. (US) | 1998-08-20 | — | — | WO | disclosed |
| WO-1998006804-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | BUSH BOAKE ALLEN INC. (US) | 1998-02-19 | — | — | WO | disclosed |